Should atrial fibrillation patients with hypertension as an additional risk factor of the CHA2DS2-VASc score receive oral anticoagulation?

Hypertension has been found to be increased a risk of stroke in atrial fibrillation (AF). Both the European and U.S. guidelines advocate the use of the CHA(2)DS(2)-VASc (congestive heart failure, hypertension, age > 75 years, diabetes mellitus, stroke/transient ischemic attack, vascular disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Juan, Zhang, Da-Peng, Liu, Hong–Bin, Zhong, Jiu–Chang, Yang, Xin–Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919811/
https://www.ncbi.nlm.nih.gov/pubmed/29721002
http://dx.doi.org/10.11909/j.issn.1671-5411.2018.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919811/
https://www.ncbi.nlm.nih.gov/pubmed/29721002
http://dx.doi.org/10.11909/j.issn.1671-5411.2018.03.005

Ejemplares similares